Organizing Committee
Biography
Post TBI patients comprehensive care for headaches and cognitive rehab, neck pain and back pain. Neuro cognitive evaluation, treatment and rehabilitation for early recovery. Dr Kumar provides forced oxygen therapy for acute and sub acute concussion/ mild traumatic brain injury and treatment of other neurological disorder routinely in his office. Comprehensive Traumatic Brain Injury Center 1. Screening for our football/basketball players/contact sports for concussion head injury 2. Immediate forced oxygen therapy for Mild TBI patients. 3. Treatment and control of physical symptoms of the MTBI 4. 1 hour EEG and MRI brain DTI test for MTBI evaluations 5. Neurocognitive testing and neuro behavioral testing with in first week of the MTBI to plan neurocognitive therapy or neuro-rehabilitation 6. Visio-spatial/Speech/ occupational/ Computer based neurocognitive therapy 7. Early recovery from MTBI with providing other support systems. Urgent Headaches Clinic 1. We treat Walk-in headache patients 2. Iv infusion and Oxygen therapy for headaches 3. Nerve blocks and Botox therapy for headaches Neurology Clinic 1. Non Narcotics treatment of headaches, neck pain, upper & lower back pain 2. Peripheral neuropathy or limb pain 3. Seizure disorder 4. Dementia 5. Post stroke therapy or other neurological disorder Gene Based Medication Therapy 1. All Our patients are enrolled in gene based medication therapy. Genetics based medication therapy to ensure the medication efficacy and decrease side effect for headaches and seizures disorders. 2. We have joined hand with John Hopkins in research study to provide gene based medication therapy. Neurology Research Center 1. Active research site for multi-center research trial 2. Active research site for our own services. 3. Publishing research to contribute and create knowledge
Research Interest
Neurology, Cognitive science
Biography
Molecular biologist interesting in iron metabolism and 5'UTR based RNA therapeutics for helping individuals suffering from neurodegenerative diseases.
Research Interest
Molecular biology, neurology
Biography
David has worked in community based mental health services in the UK for over thirty years developing services for people with complex care needs and enduring mental health problems in a career spanning the voluntary sector, local authority services, and the NHS.. From 2009 - 2011 he was the Dementia Implementation Lead for Commissioning Support for London, working with commissioners across London to improve dementia services. He is an independent writer and researcher on dementia support and services for Black and minority ethnic communities, working with a number of projects and initiatives.
Research Interest
Dementia, Mental Health
Biography
Partner at a personal injury law firm specializing in T.B.I. The National Trial Lawyers “Top 100 Trial Lawyersâ€. BS Magna Cum Laude 1990 and Juris Doctorate 1993. Vice-Chairman of B.O.D. Mothers Against Drunk Driving National. & B.O.D. Brain Injury Alliance. 20x year keynote at National Brain Injury Conferences. All honorariums donated to charities. Authored Spring Break: A True Story of Hope and Determination regarding a brain injured college student who received long-term inpatient, outpatient care and rehabilitation. Awarded: US Senate Official Proclamation, US Congressional Citation, U.S. House of Representatives Special Congressional Recognition, 20+ awards for legal and charitable accomplishments.
Research Interest
Traumatic Brain Injury
Biography
Deputy National Stroke Guide line in collaboration with Royal College Physician of UK • Prepared Stroke clinical Pathway currently used at Royal Hospital • Teacher and final MD and OMSB examiner • Speaker Sohar Second Medicine Symposium, 24/3/2013, • Speaker&Moderator 1st Kuwait North American Conference, April 2013 • OMSB Examiner 2013,2014 and up to date • Organizer &Speaker of Stroke Care Teaching Modules 1st/mar/2014 Sohar Hospital • Organizer &speaker: MS updates Sohar Hospital 2013, 2014 & Nov 20th / 2014 • Speaker & Organizer at 9GCC Neurology conference 6-8 /Nov/2014 • Contributors of the National diabetic guide line (prepared the diabetic neuropathy Module) • Chair Person & Speaker at the First Omani German Stroke Conference 21-22/Feb./2015 • Moderator 2nd Kuwait North American Conference, December 2014 • Chair Person Scientific Committee ,Organizer & Speaker 1st OMA 4-5/11/2015
Research Interest
Neurology, Medicine
Biography
Professor and head of department in Grant Medical College & Sir JJ Group of hospitals 1991-2002. Professor Emeritus - Grant Medical College & Sir JJ Group of Hospital September 2005 till date. National coordinator for World Federation of Neurology Education Continuum-CME programme since 2005. Member of the WHO International Advisory Group for the Revision of ICD 10, Diseases of the Nervous System in the area of Infections of the Nervous System - January 2010 Member - World Federation of Neurology Education Committee since 2010 till date. Chair - World Federation of Neurology Teaching Course Committee 2014.
Research Interest
Neurology
Biography
BUSINESS OWNER - MASTER KARATE INSTRUCTOR - SALES PROFESSIONAL - TEACHER Truly a Man of the World with a proven professional track record in business of increased sales, drastic volume growth and tremendous interpersonal, written and oral communication skills. Offers a strong record of performance maintaining relationships & exceeding sales plans. Sole Business Owner at Oasis Senior Advisors, a franchise in the Lehigh Valley of Pa. Proud Peace Corp Volunteer in Morocco, North Africa. Lived/ Trained Japanese Karate in Japan for SEVENTEEN YEARS. Currently teaching Japanese Karate Classes
Research Interest
Senior care, dementia care
Biography
Canadian dancer and fitness instructor, Jill Simpson, spent nearly a decade as caregiver to her father who had Lewy body dementia, a form most often associated with Parkinson’s disease. A decade later, returning to the world of dance, Jill was hired by the Alzheimer’s Society of Ontario to become as one of six Mind’s in Motion® physical activity leads in its ground breaking pilot program investigating the effects of exercise on early to mid-dementia. The more I learned, the more I kept thinking about my dad, and how this information might have helped him had I just known more about the most recent dementia research. The research led to the realization that as I dancer, as well as a fitness instructor, I was in a unique position to combine four of the most powerful activities for staving off cognitive decline: music, dance, aerobic activity, and cognitive challenge into a single program not only for those with early to mid dementia, but for a general population who simply want to keep their brains tuned up. The Body, Mind, and Movement Program™ for Brain Fitness is a unique combination of music and specific types of movement designed to stimulate blood flow to the brain, increase connectivity and communication between right and left hemispheres, and flood the brain with natural exercise-induced hormones that elevate mood and stimulate cognition. Jill has also recently trained and partnered with Dancing with Parkinson’s (DWP) Sarah Robichaud in Toronto to bring the DWP program to the Kitchener/Waterloo area. Although distinctly different, there is a great deal of overlap between the two programs as approximately 30% of those with Parkinson’s go on to develop a form of dementia, and finding alternate neural pathways is the goal of both programs.
Research Interest
Neurology
Biography
Born in 1968, he completed Medical Faculty University of Sarajevo 1997(MD degree). With IDU works since 1998 and since 1999 head of the ambulance to OST within the Mental Health Center Zenica. One of the founders of the Cantonal Institute for the disease of addiction Ze-Do Canton Zenica. In the period 2003-07 in the Cantonal Hospital Zenica and a University Clinical center in Sarajevo completed his residency in neurology and psychiatry. Medical Faculty in Sarajevo completed courses of good clinical practice and good experimental practices as well as postgraduate studies in clinical medicine(MSc degree). In the period 2013-15 ending sub-specialization in the field of addictology followed by planned training in the field of forensic psychiatry. Member of the expert group (2010-12) at the Department of Health of the Ministry of Civil Affairs, which has developed guidelines for the implementation of OST in B&H. UNODC internationally certified trainer in the field of substance abuse. The Cantonal Institute of addictions performed the following duties: a doctor in the clinic (2005-08), head of the hospital department (2008-12) a Head of all medical services and consultative addictologist. (2012-).Since 2013 employed as a forensic psychiatrist in Zenica and Busovaca prison and court expert in this field. Of the 2013 decision of the Minister of Health FB&H head of education in the field of addictology for employees Center for Mental Helath in FB&H.
Research Interest
Neurology
Biography
Advocate for the older population. Health Care Services for Older Adults through HOME VISITS. Older adults & family will be assisted in minimizing health risks through guidance and understanding of: -Personal responsibility for health status to maintain independence and control of health. -Health risk factors that occur with aging which can be modified to prevent complications and decrease risks. -Atypical responses to illnesses and treatment. -Education for compliance with medications and treatments as prescribed. -Improvement of nutrition, hydration, and activities for healthy lifestyle. -Approach to aging with the skill & enthusiasm required.
Research Interest
Aging, Nursing
Biography
Amy M. Clark, PhD is apart of the Dementia Care Ecosystem Project though UNMC and its partnership with the University of California - San Francisco. This project is funded by a 3-year, $10 million Healthcare Innovations Award from the Centers for Medicare & Medicaid. The impact of the Care Ecosystem will be studied, as it aims to support patients and their caregivers with decision-making, medications, caregiver support, online education, and, for a subset of patients, remote monitoring with smartphones, watches, and home sensors. Additionally Dr. Clark is a Visiting Professor with Nebraska Wesleyan University in the Social Work Department. Previously Amy served as the Dean of Health Professions at Nebraska Methodist College in Omaha, NE. In her role as Dean she oversaw 19 undergraduate, graduate and certificate on-ground and online programs in the health professions division. She was responsible for ensuring that the Allied Health Programs offered at NMC maintain their accreditation standards, enhance the student educational experience on campus and online through leadership of faculty and staff, strategic planning, curricular quality and efficiency, program integrity, and student satisfaction. Dr. Clark is a two-time Excellence in Teaching Award winner and has presented at local, state, and national conferences on a variety of topics related to teaching and research within the online and traditional on-ground educational settings.
Research Interest
neurology, dementia care
Biography
Born in Jammu-Tawi, India. After receiving Bachelor’s degree in Pharmaceutical Technology from the Birla Institute of Technology, Pilani, India, Rameshwar K. Sharma in 1960 entered the University of Connecticut for graduate work in Medicinal Chemistry and received his Ph.D. in 1963. Subsequently, after several Post-doctoral positions, including at the Worcester Foundation for Experimental Biology, Shrewsbury, Massachusetts, he joined the University of Tennessee Medical Center at Memphis in 1970 where he rose to the rank of Full Tenured Professor of Biochemistry and Physiology. During this period through NIH Special Fellowship he spent two-years Sabbatical as a Visiting Professor at the McArdle Laboratory University of Wisconsin, Madison, in Dr. Henry Pitot’s lab, and subsequently additional two-years Sabbatical at the NIH, Bethesda in Dr. Michael Cashel’s lab. After Full Professorship at the Case Western University and Founder and Head of the Unit of Regulatory Biology at the Cleveland Clinic Foundation, Cleveland Ohio, he joined the University of Medicine and Dentistry at New Jersey as the Professor and Head of The Unit of Regulatory and Molecular Biology. Since July 2006 he is at the Salus University as a Distinguished Professor of Biochemistry and Molecular Biology. In a period spanning four decades, his research team has dedicated itself to the advancement of the field of membrane guanylate cyclase in the vertebrate systems. A few of its core findings that have impacted this and the field of cellular signal transduction follow. (1) With the discovery of the first membrane guanylate cyclase, ANF-RGC that was also the hormone receptor of ANF, the membrane guanylate cyclase surface receptor family was established. (2) It had a unique signal transduction mechanism. Instead of GTP in G-Protein signaling, it was regulated by ATP through its ARM module (ARM). The complete dissection of the module, followed through the concept-based analysis, localized a WTAPELL motif that controlled the entire signal transduction process, it was, then, predicted that this motif is the one that controls the ANF-RGC-dependent blood pressure in vasculature. This has now been proven true through the construction of the mouse genetic model. The mice lacking this motif are hypertensive. (3) The discovery and molecular characterization of the photoreceptor ROS-GC is a land mark event in the phototransduction field. It filled in the gap on the identity of the source of cyclic GMP that serves as a second messenger of the LIGHT signal; and made it possible to explain the principles of phototransduction in molecular and physiological terms. It also impacted the core membrane guanylate cyclase field by branching it into two: a transducer of both the hormone receptor and the intracellularly-generated Ca2+ signals. (4) ROS-GC field took additional direction when it was demonstrated that, besides phototransduction, it is biochemically linked with the transduction mechanisms of the inner segments of the retina, olfactory cilia and the olfactory bulb neurons. (5) The demonstration that ROS-GC is a Ca2+-bimodal switch, generated a new revolutionary concept where theoretically ROS-GC could be modulated through two different modes of Ca2+ signaling: via Ca2+-sensor GCAPS and S100B, the latter stimulating it and the mode found exclusively in cones and absent in rods. (6) Recently, an additional model of the photoreceptor ROS-GC1 has been disclosed. ROS-GC1 is responsive to the bicarbonate signal; it is not the pH effect, rather it binds to a specific motif of the ROS-GC and transduces the signal in generation of cyclic GMP. Preliminary findings suggest that this novel transduction system is present in a small number of mouse cones, and, importantly, is absent in the rods. This opens up a new area of sensory transduction mechanism, where it is meant to communicate with the external atmospheric carbon dioxide. The carbon dioxide is sensed through carbonic anhydrase, whose subtype has been detected in some cones, it converts CO2 to the bicarbonate, which, then, becomes the second messenger of CO2 and a signaling agent of ROS-GC1. Threaded through this past history and step-by-step gain in the field, This investigator feels fortunate that his group has made these important contributions in generating the field of membrane guanylate cyclase, establishing that cyclic GMP is an ubiquitous intracellular second messenger in prokaryotes and eukaryotes and that it plays a critical role in the control of physiological processes of cardiac vasculature, smooth muscle relaxation, blood volume, cellular growth, sensory transduction, neural plasticity, learning and memory. It is also gratifying to know that during this course he has been able to train and guide more than 35 doctoral and post-doctoral students, author 184 peer-reviewed research articles, including the editorship of three books, Special Editorship of two journals of Molecular and Cellular Biochemistry and the e-book editor of the Frontiers Molecular Neuroscience Research Topic, all focused on the field of membrane guanylate cyclases. At present I am on the editorial board of four international journals: Associate editor of the Frontiers in Molecular Neuroscience, Journal of Molecular and Cellular Biochemistry, Journal of Signal Transduction, Journal of Membrane Science & Technology. I am also the founding father and the President of the Guanylate Cyclase Innovative Biotechnology
Research Interest
Neuropharmacology
Biography
Kurt A Jellinger, born 1931 in Vienna, is Professor of Neurology and Neuropathology at the Medical University of Vienna (Vienna, Austria), was director of the Department of Neurology, Lainz Hospital in Vienna and since 2002, director of the Institute of Clinical Neurobiology (Vienna, Austria). He has been the recipient of numerous international grants and awards, is a member of numerous national and international scientific societies, editor of many international journals of neurology, neuroscience and neuropathology. His publication records exceeds 1,000 in perr-reviewed journals, 170 contributions in scientific book, inclduding several as editor, as well as 1.300 lectures at international meetings. For the last 50 years, his research included many fields of clinical neuropathology, neurochemistry and descriptive neurobiology.
Research Interest
His current research is focused on the neuropathology, molecular pathology and pathogenesis of movement disorders, neurodegenerative dementias, vascular cognitive disorders, late-life dementia and problems of cell death in CNS aging.
Biography
Anne cared for her husband at home until his younger onset Frontal Temporal Dementia required Residential Care. She still actively shares in his care. Prior to this she held National Senior Executive positions in large organisations, founded her own Management Consulting business and has been involved as a Director on many Statutory Boards & Government Advisory Committees. Her career commenced as a Registered Nurse in Operating Theatre Management, before moving into strategic corporate HR/Occupational Health & Safety Management. She is an active member of Alzheimer’s Australia (Vic) ‘Consumer Advisory Committee’, the Victorian Department of Health & Human Services – ‘ Public Sector Residential Aged Care - Reference Group’ & was appointed as Victorian representative to the ‘National Consumer Advisory Committee’ of Alzheimer’s Australia 2014 . She is a regular guest speaker, promoting greater understanding about the different forms & stages of Dementia including the Behavioural, Psychological & Communication changes that arise with the development & diagnosis of Dementia. She has held a Consumer Directed Home Care Package & has been involved in many Alzheimer' Australia (Vic) projects including ‘Driving & Dementia’, 'Intimacy & Dementia' & ‘Dementia Friendly Communities’.
Research Interest
Psychology, Behavioral Sciences
Biography
Richard Semanda Founder and promoter Geriatric Respite Care Foundation Uganda, Ambassador Commonwealth Association for the Ageing (Commonage) Uganda as well as Board of Director International Association of Housing and Services for the Aging (IAHSA). Trained from Kampala International University and United Nations International Institute on Ageing in Malta. Advisor National Network of older persons of Uganda Partial trainer of health and non-health professionals Hospice AFRICA – UGANDA. Conducts training programs in Gerontology, carried out a research with WHO Geneva Department of Ageing and Life Course on the health experience of older persons in Kampala. Chairman Rise And Shine Dyslexic Organization (RASDO).
Research Interest
Ageing
Biography
Panteleimon Giannakopoulos has completed his MD at age of 23 years from the University of Athens and is board certified psychiatrist and psychotherapist from 1999. He completed his postgraduate training in London and Paris before taking the chair of old age psychiatry in Geneva. He has also a full training in cognitive neurosciences focusing on dementing conditions. He was the chairman of the Department of Psychiatry in Geneva from 2005 to 2015 before being appointed as medical director of the Forensic Psychiatry for the Geneva county. He has published more than 220 peer-reviewed articles (h index: 42), and has been serving as an editorial board member and reviwer of repute.
Research Interest
Identification of markers of cognitive decline in mild cognitive impairment, late-onset depression and bipolar disorders, Cognitive impact of vascular lesions in brain aging, Alzheimer’s disease (AD), Use of recombinant clusterin to prevent ischemic damage in organotypic cultures and after middle cerebral artery occlusion
Biography
Marco Tulio Medina, born in the city of Tegucigalpa , MDC capital of the Republic of Honduras , on September 19, 1959, is a researcher in the fields of neurology and epilepsy, currently serves as Dean of the Faculty of Medical Sciences , UNAH . Founded in 1998, the Graduate Neurology at the UNAH with the support of the World Federation of Neurology (WFN), becoming a pilot program to developing countries, thus promoting education and neurological research in Honduras.
Research Interest
epilepsy genetic, neuroâ€epidemiology and vascular endothelium
Biography
Doctor. Faculty of Medical Sciences, National University of Cuyo. Neurology residency. Private Community Hospital of Mar del Plata. Head of Residence, Residence of Neurology. Private Community Hospital of Mar del Plata. Doctor in medicine. Faculty of Medical Sciences, National University of Cuyo. Specialist in University Teaching. Faculty of Arts, National University of Cuyo.
Research Interest
Neurology, Neuropharmacology, Medical Sciences
Biography
As a post doctoral student, She is Interested in 1) Factors that enhance brain neuroplasticity, slowing the progression of neurodegenerative diseases; 2) Early surrogate biomarkers; 3) Development of new therapeutic strategies for patients with dementia; 4) Support therapies for relatives of patients with dementia and the effects of exercise and vascular risk factors in cognitive decline and dementia in the elderly.
Research Interest
dementia, vascular neurology, cognitive science
Biography
Dr. Soraya L. Valles completed her PhD in Alcohol action mechanisms with Consuelo Guerri her Director of Thesis (1996) from Instituto Investigationes Citologicas, in Valencia, Spain. Postdoctoral position in Sheffield, UK with Dr. Eva Qwarnstrom and Steve Dower. During 3.5 years, working in inflammation and IL-1R1 (from 1997 to 2000). Postdoctoral position in Spain, with Dr. Consuelo Guerri, working in alcohol and inflammation (from 2000 to 2004). Lecturer position in school of medicine, University of Valencia. Department of Physiology (from 2004 to 2008). Senior lecturer in the same University, (from 2008 to 2009). She is presently working as an Assistant professor in department of Physiology, school of medicine, University of Valencia.
Research Interest
Biochemistry, Genetics and Molecular Biology Neuroscience Medicine